Patents by Inventor Ravi Jain

Ravi Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160348100
    Abstract: Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.
    Type: Application
    Filed: April 6, 2016
    Publication date: December 1, 2016
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Vickie L. Brown-Driver, Ravi Jain
  • Patent number: 9476051
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of superoxide dismutase 1, soluble. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding superoxide dismutase 1, soluble. Methods of using these compounds for modulation of superoxide dismutase 1, soluble expression and for treatment of diseases associated with expression of superoxide dismutase 1, soluble are provided.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: October 25, 2016
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: C. Frank Bennett, Kenneth W. Dobie, Susan M. Freier, Thomas P. Condon, Ravi Jain, Richard Alan Smith, Don W. Cleveland
  • Patent number: 9447412
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: September 20, 2016
    Assignee: Regulus Therapeutics Inc.
    Inventors: Bridget Gordon, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Eric E. Swayze, Ravi Jain, Balkrishen Bhat
  • Patent number: 9295939
    Abstract: For separating carbon dioxide (CO2) from a gas stream, a substantially moisture free gas stream is produced using a first temperature swing adsorption (TSA), a first pressure swing adsorption (PSA), a first vacuum swing adsorption (VSA), membrane separation, a first absorption, or any combination thereof. CO2 is captured from the substantially moisture free gas stream and substantially dry CO2 depleted stream is produced using a second TSA, a second PSA, a second VSA, or a second absorption with a non-aqueous solvent with or without a chemical reaction. Adsorbents and/or absorbents used during moisture removal are regenerated using the substantially dry CO2 depleted stream.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: March 29, 2016
    Assignee: Innosepra LLC
    Inventor: Ravi Jain
  • Publication number: 20160048296
    Abstract: A user controls a pair of devices—a wearable electronic device, such as a watch (e.g., a smart watch) and a companion electronic device, such as a smart phone. The user takes a picture (of him or herself or of something in the environment) with the companion electronic device. The companion electronic device transfers information about attributes of the image (or, in some embodiments, transfers the image itself) to the wearable device. The wearable electronic device changes its appearance based on one or more attributes of the image, including color and the identity of objects in the picture. For example, if the wearable electronic device is a watch and the user is wearing pink, the watch could change its display to pink or to a complementary color. If user is wearing jeans (determined by object recognition, for example), the watch could change its display to a Western theme.
    Type: Application
    Filed: August 12, 2014
    Publication date: February 18, 2016
    Inventors: Su-Yin Gan, Ravi Jain
  • Publication number: 20160017329
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Application
    Filed: July 21, 2015
    Publication date: January 21, 2016
    Inventors: Christine Esau, Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Brenda F. Baker, Timothy A. Vickers, Eric G. Marcusson, Erich Koller, Eric E. Swayze, Ravi Jain, Balkrishen Bhat, Eigen Peralta
  • Patent number: 9208512
    Abstract: Apparatus and method for transferring promotional messages to a mobile communication device. A promotional message is generated for display on a mobile communication device. The promotional message is associated with an entity having a physical location. The promotional message has a plurality of different types of content each associated with a different distance between the mobile communication device and a physical location of the entity. The generated promotional message is thereafter stored in a memory. A controller selects and transfers the promotional message to the mobile communication device responsive to a detected distance between the mobile communication device and the physical location. The transferred promotional message displays, on the device, a selected one of the different types of content corresponding to the detected distance.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 8, 2015
    Assignee: Google, Inc.
    Inventors: Surojit Chatterjee, Terry Van Belle, Anshul Kothari, Jian Zhou, Paul Feng, Ravi Jain, Nandita Narasimha Prabhu, Yun Huang
  • Patent number: 9152131
    Abstract: A wearable device in one embodiment includes a motion detection sensor, an alarm clock and a sleep monitor operatively coupled to the motion detection sensor and the alarm clock. The sleep monitor monitors a person during sleep by collecting motion detection sensor data at a first data collection rate and determines a sleep state of the person based on the collected motion detection sensor data at the first data collection rate. If the sleep monitor detects that the alarm clock has entered a snooze mode, then the first data collection rate is increased to a second data collection rate and motion detection sensor data is collected at the second data collection rate while the alarm clock system in the snooze mode.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: October 6, 2015
    Assignee: Google Technology Holdings LLC
    Inventors: Maria N Mokhnatkina, Dmitri R Latypov, Ravi Jain, Mikhail Petrov
  • Patent number: 9139832
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: September 22, 2015
    Assignee: Regulus Therapeutics Inc.
    Inventors: Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Eric E. Swayze, Ravi Jain, Balkrishen Bhat
  • Patent number: 9098589
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for geographic annotation of electronic resources. In one aspect, a method includes generating a spatial index for a plurality of resources from a plurality of distinct publishers, including, for each resource of the plurality of resources: receiving a plurality of location data points for the resource, each location data point corresponding to one of a plurality of requests for the resource, and assigning each location data point for the resource to a spatial cluster of a plurality of spatial clusters, each spatial cluster corresponding to a particular geographic region. The spatial index is stored. The spatial index is used to identify a plurality of address locations for resources assigned to a spatial cluster corresponding to a first geographic region in response to a request from a requester to identify resources associated with the first geographic region.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: August 4, 2015
    Assignee: GOOGLE INC.
    Inventors: Arunesh Mishra, Ravi Jain
  • Publication number: 20150189464
    Abstract: Systems and methods for determining the geographic location of a user based on limited and ambiguous information available from the user's mobile electronic communication device are provided. In an embodiment, a computer-based system estimates a device's physical location based on partial identification information collected from the device such as the local area code and cell identification number, and numerous non-locational attributes. When the system determines that the collected information from the device corresponds to more than one single geographic location the system may use additional techniques of iterative disambiguation and filtering to determine a predicted location. Additional techniques may be used to increase the confidence level of the predicted location.
    Type: Application
    Filed: November 26, 2008
    Publication date: July 2, 2015
    Applicant: Google Inc.
    Inventors: Michael Jesse Chu, Adel Amin Youssef, Zhengrong Ji, Steven John Lee, Ravi Jain
  • Publication number: 20150184157
    Abstract: Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.
    Type: Application
    Filed: February 5, 2015
    Publication date: July 2, 2015
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: Vickie L. Brown-Driver, Ravi Jain
  • Publication number: 20150160023
    Abstract: Various aspects can be implemented to provide personalized traffic alerts. In general, one aspect can be a method that includes identifying, at a computing device, an area of interest associated with information request. The method also includes submitting to a remote computing system a request associated with the area of interest that does not identify the area of interest. The method further includes receiving, in response to the submitted request, a result corresponding to a super-area that is larger than, but includes, the area of interest. The method additionally includes identifying information within the result corresponding to the area of interest. Other implementations of this aspect include corresponding systems, apparatus, and computer program products.
    Type: Application
    Filed: October 21, 2008
    Publication date: June 11, 2015
    Applicant: Google Inc.
    Inventors: Samir Goel, Ravi Jain
  • Patent number: 9047622
    Abstract: Systems and methods for improving the delivery of interactive advertisements are discussed herein. Systems and methods include approaches and solutions for boosting the rank of certain ads and/or ad types based on a combination of their interaction type and an ad interaction history for a given user, vertical, or aggregate indicator. Systems and methods also include suppressing ads unlikely to be interacted with from ranking and format boosting based on such ad interaction history.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: June 2, 2015
    Assignee: GOOGLE INC.
    Inventors: Satyam Shaw, Ravi Jain, Surojit Chatterjee
  • Publication number: 20150124698
    Abstract: A system and method of determining a keep-alive interval for a network access point (AP) employs adaptive learning and crowd sourced data building to increase the effectiveness and efficiency of mobile device connectivity. In particular, in addition to allowing group accessed storage of resolved keep-alive intervals for specific APs, the disclosed principles provide a mechanism for resolving the keep-alive interval for any AP upon first encounter, allowing devices to maintain connectivity during a session without consuming bandwidth unnecessarily by sending superfluous keep-alive messages.
    Type: Application
    Filed: December 20, 2013
    Publication date: May 7, 2015
    Applicant: Motorola Mobility LLC
    Inventors: Ravi Jain, Maria N. Mokhnatkina, Balaji Thiagarajan, Lakahmi Thyagarajan
  • Patent number: 8895529
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: November 25, 2014
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Xing-Xian Yu, Susan M. Freier, Ravi Jain
  • Publication number: 20140336370
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Application
    Filed: April 4, 2014
    Publication date: November 13, 2014
    Applicant: REGULUS THERAPEUTICS INC.
    Inventors: Christine Esau, Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Brenda F. Baker, Timothy A. Vickers, Eric G. Marcusson, Erich Koller, Eric E. Swayze, Ravi Jain, Balkrishen Bhat, Eigen Peralta
  • Publication number: 20140329882
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Application
    Filed: April 4, 2014
    Publication date: November 6, 2014
    Applicant: REGULUS THERAPEUTICS INC.
    Inventors: Christine Esau, Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Brenda F. Baker, Timothy A. Vickers, Eric G. Marcusson, Erich Koller, Eric E. Swayze, Ravi Jain, Balkrishen Bhat, Eigen Peralta
  • Patent number: 8880323
    Abstract: A computer-implemented method includes obtaining road sensor data reflecting speeds of traffic on road segments, transforming the road sensor data using vehicle probe data for the road segments reflecting vehicle speeds, and producing speed estimates for the road segments using the transformed road sensor data. The method can further include determining speeds for road segments between road sensors by smoothing data from sensors near the road segments.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: November 4, 2014
    Assignee: Google Inc.
    Inventors: Ravi Jain, Samir Goel, Gregory Neverov
  • Patent number: 8865884
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of kinesin-like 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding kinesin-like 1. Methods of using these compounds for modulation of kinesin-like 1 expression and for treatment of diseases associated with expression of kinesin-like 1 are provided.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: October 21, 2014
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Kenneth W. Dobie, Erich Koller, Ravi Jain